Antimicrobial and anti-biofilm potencies of dermcidin-derived peptide DCD-1L against Acinetobacter baumannii: an in vivo wound healing model

[1]  P. Falabella,et al.  Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields , 2021, Frontiers in Cellular and Infection Microbiology.

[2]  Runhui Liu,et al.  Therapeutic strategies against bacterial biofilms , 2021 .

[3]  Yue Ding,et al.  Contribution of the AbaI/AbaR Quorum Sensing System to Resistance and Virulence of Acinetobacter baumannii Clinical Strains , 2020, Infection and drug resistance.

[4]  M. Pourhajibagher,et al.  Photodisinfection effects of silver sulfadiazine nanoliposomes doped-curcumin on Acinetobacter baumannii: a mouse model. , 2020, Nanomedicine.

[5]  Zhi-Ye Zhang,et al.  Antimicrobial peptides: new hope in the war against multidrug resistance , 2019, Zoological research.

[6]  Quan-yong He,et al.  The antimicrobial peptides and their potential clinical applications. , 2019, American journal of translational research.

[7]  M. E. El Zowalaty,et al.  Acinetobacter baumannii biofilms: effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments , 2018, Infection and drug resistance.

[8]  J. Navas,et al.  Acinetobacter baumannii maintains its virulence after long-time starvation , 2018, PloS one.

[9]  R. Hancock,et al.  Design and Assessment of Anti-Biofilm Peptides: Steps Toward Clinical Application , 2018, Journal of Innate Immunity.

[10]  F. Gao,et al.  Novel Self-assembled Organic Nanoprobe for Molecular Imaging and Treatment of Gram-positive Bacterial Infection , 2018, Theranostics.

[11]  S. Shoja,et al.  Growth Rate and Biofilm Formation Ability of Clinical and Laboratory-Evolved Colistin-Resistant Strains of Acinetobacter baumannii , 2018, Front. Microbiol..

[12]  R. Hancock,et al.  Synthetic Peptides to Target Stringent Response-Controlled Virulence in a Pseudomonas aeruginosa Murine Cutaneous Infection Model , 2017, Front. Microbiol..

[13]  R. Kanungo,et al.  Biofilm formation as a virulence factor of Acinetobacter baumannii: An emerging pathogen in critical care units , 2017 .

[14]  A. Monzavi,et al.  Real-time quantitative reverse transcription-PCR analysis of expression stability of Aggregatibacter actinomycetemcomitans fimbria-associated gene in response to photodynamic therapy. , 2017, Photodiagnosis and photodynamic therapy.

[15]  A. Bahador,et al.  In Vitro Antimicrobial Activity of Dermcidin-1L Against Extensively-Drug-Resistant and Pandrug-Resistant Acinetobacter baumannii , 2017 .

[16]  S. Sitthisak,et al.  Distribution of virulence genes involved in biofilm formation in multi-drug resistant Acinetobacter baumannii clinical isolates. , 2016, International microbiology : the official journal of the Spanish Society for Microbiology.

[17]  M. Otto,et al.  Bacterial strategies of resistance to antimicrobial peptides , 2016, Philosophical Transactions of the Royal Society B: Biological Sciences.

[18]  Saad B. Almasaudi.  Acinetobacter spp. as nosocomial pathogens: Epidemiology and resistance features , 2016, Saudi journal of biological sciences.

[19]  A. Bahador,et al.  Wide distribution of carbapenem resistant Acinetobacter baumannii in burns patients in Iran , 2015, Front. Microbiol..

[20]  Y. Shai,et al.  Mechanisms of biofilm inhibition and degradation by antimicrobial peptides. , 2015, The Biochemical journal.

[21]  U. Kim,et al.  Update on the Epidemiology, Treatment, and Outcomes of Carbapenem-resistant Acinetobacter infections , 2014, Chonnam medical journal.

[22]  C. Tang,et al.  The sensor kinase BfmS mediates virulence in Acinetobacter baumannii. , 2014, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[23]  R. Hancock,et al.  A Broad-Spectrum Antibiofilm Peptide Enhances Antibiotic Action against Bacterial Biofilms , 2014, Antimicrobial Agents and Chemotherapy.

[24]  P. Stewart,et al.  Biofilms and Inflammation in Chronic Wounds. , 2013, Advances in wound care.

[25]  S. Dosler,et al.  In Vitro Activities of Antibiotics and Antimicrobial Cationic Peptides Alone and in Combination against Methicillin-Resistant Staphylococcus aureus Biofilms , 2012, Antimicrobial Agents and Chemotherapy.

[26]  B. Schittek.  The Multiple Facets of Dermcidin in Cell Survival and Host Defense , 2012, Journal of Innate Immunity.

[27]  Xiaolin Tian,et al.  Quorum Sensing and Bacterial Social Interactions in Biofilms , 2012, Sensors.

[28]  V. Korolik,et al.  Inhibition of Bacterial Biofilm Formation and Swarming Motility by a Small Synthetic Cationic Peptide , 2012, Antimicrobial Agents and Chemotherapy.

[29]  J. Vila,et al.  The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace , 2012, Front. Microbio..

[30]  M. Habeck,et al.  Structure-Activity Analysis of the Dermcidin-derived Peptide DCD-1L, an Anionic Antimicrobial Peptide Present in Human Sweat* , 2012, The Journal of Biological Chemistry.

[31]  K. Rigby,et al.  Staphylococcus aureus Mutant Screen Reveals Interaction of the Human Antimicrobial Peptide Dermcidin with Membrane Phospholipids , 2009, Antimicrobial Agents and Chemotherapy.

[32]  G. Pier,et al.  The pgaABCD Locus of Acinetobacter baumannii Encodes the Production of Poly-β-1-6-N-Acetylglucosamine, Which Is Critical for Biofilm Formation , 2009, Journal of bacteriology.

[33]  Aaron Weinberg,et al.  The roles of antimicrobial peptides in innate host defense. , 2009, Current pharmaceutical design.

[34]  H. Benson,et al.  Skin peptides: biological activity and therapeutic opportunities. , 2008, Journal of pharmaceutical sciences.

[35]  R. Hancock,et al.  Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation , 2008, Infection and Immunity.

[36]  J. Schlager,et al.  In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[37]  C. Garbe,et al.  Dermcidin is constitutively produced by eccrine sweat glands and is not induced in epidermal cells under inflammatory skin conditions , 2004, The British journal of dermatology.

[38]  Kevin Francis,et al.  Direct Continuous Method for Monitoring Biofilm Infection in a Mouse Model , 2003, Infection and Immunity.

[39]  M. Rajeevan,et al.  Use of real-time quantitative PCR to validate the results of cDNA array and differential display PCR technologies. , 2001, Methods.

[40]  M. Pourhajibagher,et al.  Assessment of biofilm formation among Acinetobacter baumannii strainsisolated from burned patients , 2016 .

[41]  A. Rodrigues,et al.  In vivo antibiofilm effect of cerium, chitosan and hamamelitannin against usual agents of catheter-related bloodstream infections. , 2013, The Journal of antimicrobial chemotherapy.

[42]  P. Stewart,et al.  Modelling protection from antimicrobial agents in biofilms through the formation of persister cells. , 2005, Microbiology.

[43]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[44]  M. Ferraro.  Performance standards for antimicrobial susceptibility testing , 2001 .